Patients with L1CAM-positive endometrioid carcinomas showed shorter recurrence-free survival in the univariate analysis, and despite a multivariate analysis mentioned in the discussion [21], these data are not presented to further understand the independent or non-independent role of L1CAM expression. Here, L1CAM is linked to endometrioid adenocarcinoma.